The "Medical Association Innovation Exchange Series of Academic Conferences and Chronic Disease Risk Factors Long-Term Management Series (14th Edition)," hosted by the Chengdu High-Tech Medical Association, was successfully held online on December 28, 2024. With the aim of "serving grassroots healthcare and clinical practice," the conference focused on new technologies and therapies for the diagnosis and treatment of cardiovascular diseases. It attracted numerous cardiologists and general practitioners to participate.

The meeting facilitated in-depth discussions on clinical practices and cutting-edge advancements in the management of coronary heart disease, hypertension, and lipid control. It provided an excellent platform for exchanging insights on improving the prevention and treatment of cardiovascular diseases, promoting standardized treatment protocols for hypertension and coronary heart disease, and enhancing grassroots physicians' understanding and application of novel medications. Additionally, the conference emphasized optimizing drug selection based on patient characteristics, balancing efficacy and safety, and strengthening follow-up and comprehensive interventions for chronic disease patients.